相关实验视频
Updated: Jan 10, 2026

12:08
Diagonal Method to Measure Synergy Among Any Number of Drugs
Published on: June 21, 2018
19.4K
桥Syn:用于药物组合协同预测的桥梁融合框架
Qingyu Wang1, Suwan Mao1, Xiaoyan Liu2
1Department of Medical Informatics, School of Biomedical Engineering and Informatics, Nanjing Medical University, 101 Longmian Avenue, Jiangning District, Nanjing, 211166 Jiangsu, China.
Briefings in bioinformatics
|November 21, 2025
概括
预测药物协同作用对于治疗复杂疾病至关重要. 我们的新BridgeSyn框架有效地融合了药物和细胞系数据,优于现有的超级协同预测方法.
科学领域:
- 计算生物学是一种计算生物学.
- 药理学 药理学是指药理学的学科.
- 生物信息学是一种生物信息学.
背景情况:
- 药物组合为复杂疾病提供治疗潜力.
- 预测药物协同作用具有挑战性,因为有效组合的比例很小.
- 准确的药物协同作用预测对于推进组合疗法至关重要.
研究的目的:
- 开发一个新的框架,BridgeSyn,用于准确的药物协同作用预测.
- 利用预训练的生物语言模型来增强药物和细胞系的表现.
- 引入一个有效的融合桥梁机制,以整合多式联络生物数据.
主要方法:
- 利用预训练的生物语言模型来丰富药物化合物和细胞系特征.
- 开发了一个桥梁融合机制,共享隐藏令牌用于语义数据集成.
- 采用融合策略,将生物先验知识与深度学习方法相结合.
主要成果:
- 与现有的计算方法相比,BridgeSyn在药物协同效应预测方面表现出卓越的性能.
- 在两个公共数据集上进行了广泛的实验,验证了拟议框架的有效性.
- 桥梁融合机制成功捕获了复杂的生物相互作用,以准确预测.
结论:
- 桥Syn为预测药物协同作用提供了一种强大而有效的方法.
- 该框架整合生物知识的能力提高了预测准确度.
- 布里奇Syn代表了药物组合发现计算方法的重大进步.
相关概念视频
Combined Effects of Drugs: Synergism
6.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
6.7K
Drug Discovery: Overview
10.9K
Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
10.9K
Drug-Receptor Interactions
7.2K
Drug-receptor interaction describes the binding of receptors by drugs, but not all drug-receptor interactions result in activation and tissue response. For instance, the binding of agonists activates the receptor to generate a cellular reaction, while antagonists bind to receptors without causing their activation.
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue....
7.2K
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Combined Effects of Drugs: Antagonism
11.5K
The combined effects of drugs can result in various interactions, of which an important type is antagonism. Antagonism is a mechanism where one drug inhibits or counteracts the effects of another drug. Antagonism can occur through various means, including receptor binding, allosteric modulation, functional interaction, chemical reactions, and pharmacokinetic processes.
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
The most common type is receptor antagonism, where one drug acts as an antagonist to block the effects of another drug by...
11.5K
Drug-Receptor Bonds
4.2K
Drug-receptor bonds are formed through various chemical forces when drugs interact with target cells. Covalent bonds, strong and irreversible, are exemplified by DNA-alkylating anticancer agents that inhibit cell division. However, such irreversible drug binding lacks selectivity and can modify the DNA of the surrounding healthy cells. Covalent binding often contributes to tissue toxicity, as seen with chloroform and paracetamol metabolites binding to the liver, causing hepatotoxicity.
In...
In...
4.2K

